• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and RAI-1 content and distribution.

作者信息

Robbie L A, Young S P, Bennett B, Booth N A

机构信息

Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Scotland, UK.

出版信息

Thromb Haemost. 1997 Mar;77(3):510-5.

PMID:9066003
Abstract

We have previously shown that whole blood clots prepared under static conditions are a poor model for human thrombi formed in vivo. The most striking contrast is in the PAI-1 content, some 100 times lower in static clots than in human thrombi. This study aimed to evaluate thrombi formed in an artificial circulation (Chandler loop) using whole blood augmented with platelets. Citrated blood was recalcified and placed in tubing, which was sealed to form a closed loop and circulated. Immunohistochemical staining revealed morphology very similar to human thrombi formed in vivo, comprising dense platelet-rich heads and fibrin-rich tails. Strong positive staining for PAI-1 was observed in fibrin-rich areas of both the head and the tail. The PAI-1 content of the thrombi increased significantly on augmentation of blood with isolated platelets, and reached levels comparable with those in human thrombi. These Chandler thrombi thus provide an appropriate model system for the study of thrombus lysis. in contrast to static blood clots.

摘要

相似文献

1
Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and RAI-1 content and distribution.
Thromb Haemost. 1997 Mar;77(3):510-5.
2
PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood.纤溶酶原激活物抑制剂-1(PAI-1)抑制作用可增强体外形成的类动脉血栓富含血小板部分的溶解。一项使用大鼠和人血液制备的血栓进行的对比研究。
Blood Coagul Fibrinolysis. 1998 Jan;9(1):11-8. doi: 10.1097/00001721-199801000-00002.
3
Proteins of the fibrinolytic system in human thrombi.人类血栓中纤维蛋白溶解系统的蛋白质。
Thromb Haemost. 1996 Jan;75(1):127-33.
4
Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.从活化血小板释放的纤溶酶原激活物抑制剂-1在溶栓抵抗中起关键作用。对钱德勒环路中形成的血栓进行的研究。
Arterioscler Thromb. 1994 Sep;14(9):1452-8. doi: 10.1161/01.atv.14.9.1452.
5
Properties of thrombolytic agents in vitro using a perfusion circuit attaining shear stress at physiological levels.使用能达到生理水平剪切应力的灌注回路在体外研究溶栓剂的特性。
Thromb Haemost. 1990 Dec 28;64(4):550-5.
6
Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.剪切应力和 tPA 浓度在血栓溶栓潜能中的作用。
Int J Mol Sci. 2021 Feb 20;22(4):2115. doi: 10.3390/ijms22042115.
7
High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi.猪冠状动脉血栓中活性纤溶酶原激活物抑制剂-1的高浓度
Arterioscler Thromb Vasc Biol. 1996 Oct;16(10):1277-84. doi: 10.1161/01.atv.16.10.1277.
8
Activated inflammatory cells participate in thrombus size through tissue factor and plasminogen activator inhibitor-1 in acute coronary syndrome: Immunohistochemical analysis.激活的炎症细胞通过组织因子和纤溶酶原激活物抑制剂-1 参与急性冠脉综合征中的血栓大小:免疫组化分析。
Thromb Res. 2011 May;127(5):443-9. doi: 10.1016/j.thromres.2011.02.001. Epub 2011 Mar 9.
9
A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.一种在人类血栓形成的体外模型中定量流动的天然血液中血小板沉积的新方法。
Thromb Haemost. 1998 Jan;79(1):162-8.
10
Adhesion of leukocytes to growing arterial thrombi.白细胞与正在形成的动脉血栓的黏附。
Thromb Haemost. 1998 Nov;80(5):852-8.

引用本文的文献

1
Analysis of gradual diameter thrombectomy stent .逐步直径血栓切除术支架分析
Transl Neurosci. 2025 Jan 18;16(1):20220351. doi: 10.1515/tnsci-2022-0351. eCollection 2025 Jan 1.
2
Deconstructing fibrin(ogen) structure.解析纤维蛋白(原)结构。
J Thromb Haemost. 2025 Feb;23(2):368-380. doi: 10.1016/j.jtha.2024.10.024. Epub 2024 Nov 12.
3
Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model.在体外溶栓模型中跟踪切变流下 Chandler 环形成的全血血栓的纤溶作用。
J Vis Exp. 2024 Apr 19(206). doi: 10.3791/66524.
4
Flow affects the structural and mechanical properties of the fibrin network in plasma clots.血流会影响血浆凝块中纤维蛋白网络的结构和力学性能。
J Mater Sci Mater Med. 2024 Jan 29;35(1):8. doi: 10.1007/s10856-024-06775-1.
5
Real-time tracking of fibrinolysis under constant wall shear and various pulsatile flows in an in-vitro thrombolysis model.在体外溶栓模型中,在恒定壁面剪切力和各种脉动流条件下对纤维蛋白溶解进行实时跟踪。
Bioeng Transl Med. 2023 Apr 11;8(3):e10511. doi: 10.1002/btm2.10511. eCollection 2023 May.
6
Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi.位置、位置、位置:血栓中的纤维蛋白、细胞及纤维蛋白溶解因子
Front Cardiovasc Med. 2023 Jan 18;9:1070502. doi: 10.3389/fcvm.2022.1070502. eCollection 2022.
7
"Going with the flow" in modeling fibrinolysis.纤维蛋白溶解建模中的“顺应潮流”
Front Cardiovasc Med. 2022 Dec 2;9:1054541. doi: 10.3389/fcvm.2022.1054541. eCollection 2022.
8
Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?大动物急性缺血性脑卒中模型比较:应该选择哪种模型?
Stroke. 2022 Apr;53(4):1411-1422. doi: 10.1161/STROKEAHA.121.036050. Epub 2022 Feb 15.
9
Experimental Evaluation of the Effectiveness of Aspiration-Based Techniques to Treat Different Types of Acute Thromboembolic Occlusions in the Femoropopliteal Vascular System Using an In Vitro Flow Model.应用体外血流模型评估基于抽吸的技术治疗股腘血管系统不同类型急性血栓栓塞闭塞的有效性的实验研究。
Cardiovasc Intervent Radiol. 2022 Feb;45(2):228-235. doi: 10.1007/s00270-021-03024-8. Epub 2021 Dec 17.
10
Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.剪切应力和 tPA 浓度在血栓溶栓潜能中的作用。
Int J Mol Sci. 2021 Feb 20;22(4):2115. doi: 10.3390/ijms22042115.